Advance articles
-
Accepted Manuscript
Meeting Report 20 May 2025
Survivorship from Pediatric and Adult Brain Tumors The 2024 Brain Tumor Epidemiology Consortium Meeting Report
Scott L Coven and othersNeuro-Oncology Advances, vdaf095, https://doi.org/10.1093/noajnl/vdaf095Published: 20 May 2025 Section: Meeting Report -
Accepted Manuscript
Research Article 20 May 2025
Long-term family outcomes in grade 2 IDH-mutated glioma patients treated with awake-guided surgery: biological, professional, and therapeutic interactions
Sam Ng and Hugues DuffauNeuro-Oncology Advances, vdaf102, https://doi.org/10.1093/noajnl/vdaf102Published: 20 May 2025 Section: CLINICAL INVESTIGATIONS -
Accepted Manuscript
Research Article 18 May 2025
Health-related Quality of Life and Psychological Distress in Patients with Brain Tumors and Their Families: a Cross-sectional Web Survey
Iori Sato and othersNeuro-Oncology Advances, vdaf098, https://doi.org/10.1093/noajnl/vdaf098Published: 18 May 2025 Section: CLINICAL INVESTIGATIONS -
Accepted Manuscript
Research Article 18 May 2025
Dual targeting of CD155/TIGIT and PD-L1/PD-1 Immune Checkpoints Potentiates NK Cell-mediated Cytotoxicity in Medulloblastoma
Matthijs Monnikhof and othersNeuro-Oncology Advances, vdaf099, https://doi.org/10.1093/noajnl/vdaf099Published: 18 May 2025 Section: Basic and Translational Investigations -
Accepted Manuscript
Research Article 17 May 2025
Selumetinib in pediatric patients with neurofibromatosis type 1 and plexiform neurofibroma: Propensity score analysis of SPRINT vs. natural history control arm
Ayo Adeyemi and othersNeuro-Oncology Advances, vdaf101, https://doi.org/10.1093/noajnl/vdaf101Published: 17 May 2025 Section: CLINICAL INVESTIGATIONS -
Accepted Manuscript
Research Article 17 May 2025
Profiling the immune tumor microenvironment of pediatric brain tumors with Cavitron Ultrasonic Surgical Aspirator (CUSA) derived tissue fragments
Joyce I Meesters-Ensing and othersNeuro-Oncology Advances, vdaf097, https://doi.org/10.1093/noajnl/vdaf097Published: 17 May 2025 Section: Basic and Translational Investigations -
Accepted Manuscript
Article Commentary 17 May 2025
Potential synergism of abemaciclib with chloroquine and disulfiram/copper in atypical meningioma: a case report and review of the literature
Mark Willy L Mondia and othersNeuro-Oncology Advances, vdaf096, https://doi.org/10.1093/noajnl/vdaf096Published: 17 May 2025 Section: Molecular Tumor Board Case Report -
Accepted Manuscript
Research Article 13 May 2025
PNOC009: Convection-enhanced delivery of liposomal irinotecan in patients with newly diagnosed diffuse intrinsic pontine glioma
Sabine Mueller and othersNeuro-Oncology Advances, vdaf093, https://doi.org/10.1093/noajnl/vdaf093Published: 13 May 2025 Section: CLINICAL INVESTIGATIONS -
Accepted Manuscript
Research Article 7 May 2025
Risk Factors, Predictive Models, and General Work Ability Trajectory in Patients with Glioma
Xin’er Yuan and othersNeuro-Oncology Advances, vdaf094, https://doi.org/10.1093/noajnl/vdaf094Published: 7 May 2025 Section: CLINICAL INVESTIGATIONS -
Accepted Manuscript
Research Article 7 May 2025
Identifying targetable alterations predictive of distant progression in glioblastoma patients undergoing standard therapy
Shivani Chiranth and othersNeuro-Oncology Advances, vdaf092, https://doi.org/10.1093/noajnl/vdaf092Published: 7 May 2025 Section: CLINICAL INVESTIGATIONS -
Accepted Manuscript
Research Article 7 May 2025
Arterial Spin Labeling Perfusion MRI Differentiates Between Radiation Necrosis and Tumor in Brain Metastases Treated with Stereotactic Radiosurgery
Henry H Nguyen and othersNeuro-Oncology Advances, vdaf091, https://doi.org/10.1093/noajnl/vdaf091Published: 7 May 2025 Section: CLINICAL INVESTIGATIONS -
Accepted Manuscript
Research Article 5 May 2025
Refinement of primary central nervous system lymphoma prognostication and response assessment using 3-Dimensional MRI
Jack O’Shaughnessy and othersNeuro-Oncology Advances, vdaf090, https://doi.org/10.1093/noajnl/vdaf090Published: 5 May 2025 Section: CLINICAL INVESTIGATIONS -
Accepted Manuscript
Research Article 2 May 2025
Microstructural differentiation of cerebral metastases, glioblastoma, meningioma and primary CNS lymphoma using advanced diffusion imaging techniques
Urs Würtemberger and othersNeuro-Oncology Advances, vdaf076, https://doi.org/10.1093/noajnl/vdaf076Published: 2 May 2025 Section: Basic and Translational Investigations -
Accepted Manuscript
Research Article 2 May 2025
Predicting cognitive function three months after surgery in patients with a glioma
Sander Martijn Boelders and othersNeuro-Oncology Advances, vdaf081, https://doi.org/10.1093/noajnl/vdaf081Published: 2 May 2025 Section: Basic and Translational Investigations -
Accepted Manuscript
Research Article 28 April 2025
MultiCubeNet: multitask deep learning for molecular subtyping and prognostic prediction in gliomas
Hongbo Zhang and othersNeuro-Oncology Advances, vdaf079, https://doi.org/10.1093/noajnl/vdaf079Published: 28 April 2025 Section: Basic and Translational Investigations -
Accepted Manuscript
Research Article 28 April 2025
Second-line temozolomide in first recurrent MGMT-methylated glioblastoma after lomustine/temozolomide: efficacy and safety
Thomas Zeyen and othersNeuro-Oncology Advances, vdaf084, https://doi.org/10.1093/noajnl/vdaf084Published: 28 April 2025 Section: CLINICAL INVESTIGATIONS -
Accepted Manuscript
Research Article 28 April 2025
Molecular alterations in IDH-mutant astrocytoma: A multi-institutional retrospective study
Keng Lam and othersNeuro-Oncology Advances, vdaf088, https://doi.org/10.1093/noajnl/vdaf088Published: 28 April 2025 Section: CLINICAL INVESTIGATIONS -
Accepted Manuscript
Research Article 25 April 2025
Deciphering the contributions of fecal microbiota from patients with high-grade glioma to tumor development in a humanized microbiome mouse model of glioma
Cheng Wang and othersNeuro-Oncology Advances, vdaf085, https://doi.org/10.1093/noajnl/vdaf085Published: 25 April 2025 Section: Basic and Translational Investigations -
Accepted Manuscript
Research Article 24 April 2025
Outcomes of Pediatric Medulloblastoma in Low- and Middle-Income Countries: A Retrospective Analysis of 335 Cases from 8 Countries
Rosdali Y Diaz-Coronado and othersNeuro-Oncology Advances, vdaf086, https://doi.org/10.1093/noajnl/vdaf086Published: 24 April 2025 Section: CLINICAL INVESTIGATIONS -
Accepted Manuscript
Research Article 24 April 2025
Primary CNS Lymphoma: Predictors of Response to Induction Therapy and Patterns of Progression
Louis Cappelli and othersNeuro-Oncology Advances, vdaf082, https://doi.org/10.1093/noajnl/vdaf082Published: 24 April 2025 Section: CLINICAL INVESTIGATIONS -
Accepted Manuscript
Research Article 24 April 2025
Brain CD73 modulates interferon signaling to regulate glioblastoma invasion
Konstantina Kyritsi and othersNeuro-Oncology Advances, vdaf080, https://doi.org/10.1093/noajnl/vdaf080Published: 24 April 2025 Section: Basic and Translational Investigations -
Accepted Manuscript
Research Article 24 April 2025
Phase II study of axitinib in patients with NF2-related schwannomatosis and progressive vestibular schwannomas
Mekka R Garcia and othersNeuro-Oncology Advances, vdaf083, https://doi.org/10.1093/noajnl/vdaf083Published: 24 April 2025 Section: CLINICAL INVESTIGATIONS -
Accepted Manuscript
Research Article 22 April 2025
Feasibility and efficacy of MEMMAT-like regimen in heavily pretreated adult patients with recurrent malignant embryonal brain tumors: A series of 6 cases
Aurelien Maureille and othersNeuro-Oncology Advances, vdaf071, https://doi.org/10.1093/noajnl/vdaf071Published: 22 April 2025 Section: CLINICAL INVESTIGATIONS -
Accepted Manuscript
Research Article 17 April 2025
Imaging The Effects of Treatment with TERT and EGFR Inhibitors on Glioblastoma – an MR study
Donghyun Hong and othersNeuro-Oncology Advances, vdaf078, https://doi.org/10.1093/noajnl/vdaf078Published: 17 April 2025 Section: Basic and Translational Investigations -
Accepted Manuscript
Research Article 17 April 2025
High-Grade, Metastatic Disease, and Adjuvant Radiotherapy are Independent Prognostic Factors for Progression-Free Survival in Patients with Solitary Fibrous Tumors
Jan Paul Alker and othersNeuro-Oncology Advances, vdaf077, https://doi.org/10.1093/noajnl/vdaf077Published: 17 April 2025 Section: CLINICAL INVESTIGATIONS -
Accepted Manuscript
Research Article 27 March 2025
Repurposing the anthelmintic drug mebendazole in combination with radiation therapy in an IDH mutant glioma model
Alex Shimura Yamashita and othersNeuro-Oncology Advances, vdaf066, https://doi.org/10.1093/noajnl/vdaf066Published: 27 March 2025 Section: Basic and Translational Investigations -
Accepted Manuscript
Brief Report 23 March 2025
Pan-RAS Inhibitor RMC-7977 Is Efficacious in Treating NF1-Related Tumors
Ren-Yuan Bai and othersNeuro-Oncology Advances, vdaf065, https://doi.org/10.1093/noajnl/vdaf065Published: 23 March 2025 Section: Brief Communication -
Accepted Manuscript
Research Article 22 March 2025
Defining the recommended gray zone in MGMT promoter methylation pyrosequencing reporting: a robust, translatable method to implement new EANO guidelines
Polly Taylor and othersNeuro-Oncology Advances, vdaf061, https://doi.org/10.1093/noajnl/vdaf061Published: 22 March 2025 Section: Basic and Translational Investigations -
Accepted Manuscript
Article Commentary 8 March 2025
Pleomorphic xanthoastrocytoma with anaplasia and BEND5-NTRK2 fusion in a young adult with a history of cranial radiation for childhood rhabdomyosarcoma
Julie M Fischer and othersNeuro-Oncology Advances, vdaf052, https://doi.org/10.1093/noajnl/vdaf052Published: 8 March 2025 Section: Molecular Tumor Board Case Report -
Accepted Manuscript
Research Article 18 February 2025
Distinct Gut Microbiota Composition in Pediatric Patients with Central Nervous System (CNS) Tumors: A Comparative Study
Chiara Dossena and othersNeuro-Oncology Advances, vdaf042, https://doi.org/10.1093/noajnl/vdaf042Published: 18 February 2025 Section: Basic and Translational Investigations -
Accepted Manuscript
Research Article 6 January 2025
Nuances in Visual Rehabilitation After Pituitary Surgery
Saksham Gupta and Wenya Linda BiNeuro-Oncology Advances, vdae087, https://doi.org/10.1093/noajnl/vdae087Published: 6 January 2025 Section: Pituitary Supplement Article -
Accepted Manuscript
Research Article 2 January 2025
Current understanding of the role of DNA methylation in pituitary neuroendocrine tumors
Racheal Peterson and othersNeuro-Oncology Advances, vdae149, https://doi.org/10.1093/noajnl/vdae149Published: 2 January 2025 Section: Pituitary Supplement Article -
Accepted Manuscript
Research Article 2 January 2025
Clinical Integration and Application of the 2022 WHO Pituitary Tumor Classification
Sylvia L Asa and othersNeuro-Oncology Advances, vdae145, https://doi.org/10.1093/noajnl/vdae145Published: 2 January 2025 Section: Pituitary Supplement Article -
Accepted Manuscript
Research Article 2 January 2025
Aggressive Pituitary Tumors and Pituitary Carcinomas: definition, management and overview for clinical practice
Francesco Calvanese and othersNeuro-Oncology Advances, vdae114, https://doi.org/10.1093/noajnl/vdae114Published: 2 January 2025 Section: Pituitary Supplement Article -
Accepted Manuscript
Research Article 2 January 2025
Beyond the Sella: expanded endoscopic endonasal approaches for pituitary tumors
Erion Junior de Andrade and othersNeuro-Oncology Advances, vdae086, https://doi.org/10.1093/noajnl/vdae086Published: 2 January 2025 Section: Pituitary Supplement Article -
Accepted Manuscript
Research Article 2 January 2025
Mimickers of Pituitary Tumors
M Citlalli Perez-Guzman and othersNeuro-Oncology Advances, vdae085, https://doi.org/10.1093/noajnl/vdae085Published: 2 January 2025 Section: Pituitary Supplement Article -
Accepted Manuscript
Research Article 19 December 2024
Stereotactic Radiosurgery and Fractionated Radiation therapy in the management of pituitary tumors
Georgios Mantziaris and othersNeuro-Oncology Advances, vdae010, https://doi.org/10.1093/noajnl/vdae010Published: 19 December 2024 Section: Pituitary Supplement Article